investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm
Andrew M Evens
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Elizaveta V Benevolenskaya
RBP2 Regulation Through Differential Recruitment to Genomic Loci
Non-Hodgkin lymphoma
Pathology
Scott H Kaufmann
Anticancer Drug-Induced BH3-only Protein.Bak Interactions
Non-Hodgkin lymphoma
Pathology
Eduardo Sotomayor
T-Cell Lymphoma Research, Research Radiology Collaborations
Non-Hodgkin lymphoma
Pathology
William Figg
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
Non-Hodgkin lymphoma
Pathology
David L Woodland
Immune Evolution in Cancer
Non-Hodgkin lymphoma
Pathology
John Nicholas
BH3-only Protein Targeting by HHV-8
Non-Hodgkin lymphoma
Pathology
Micah A Luftig
Host Pathways Regulating Epstein-Barr Virus-Mediated B Cell Growth Transformation
Non-Hodgkin lymphoma
Pathology
Ulf Klein
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
Non-Hodgkin lymphoma
Pathology
Oliver W Press
Pretargeted Radioimmunotherapy of CD20+ Lymphomas
Non-Hodgkin lymphoma
Pathology
